<bill session="114" type="h" number="2536" updated="2019-02-14T23:14:42Z">
  <state datetime="2015-05-21">REFERRED</state>
  <status>
    <introduced datetime="2015-05-21"/>
  </status>
  <introduced datetime="2015-05-21"/>
  <titles>
    <title type="short" as="introduced">Recovery Enhancement for Addiction Treatment Act</title>
    <title type="short" as="introduced">TREAT Act</title>
    <title type="official" as="introduced">To provide access to medication-assisted therapy, and for other purposes.</title>
    <title type="display">TREAT Act</title>
  </titles>
  <sponsor bioguide_id="H001038"/>
  <cosponsors>
    <cosponsor bioguide_id="B001269" joined="2016-04-11"/>
    <cosponsor bioguide_id="B000574" joined="2015-09-25"/>
    <cosponsor bioguide_id="C001101" joined="2015-07-29"/>
    <cosponsor bioguide_id="C001068" joined="2015-06-02"/>
    <cosponsor bioguide_id="D000623" joined="2016-01-13"/>
    <cosponsor bioguide_id="D000622" joined="2015-12-17"/>
    <cosponsor bioguide_id="E000293" joined="2015-12-16"/>
    <cosponsor bioguide_id="F000454" joined="2016-03-02"/>
    <cosponsor bioguide_id="G000574" joined="2015-12-17"/>
    <cosponsor bioguide_id="G000564" joined="2015-06-09"/>
    <cosponsor bioguide_id="G000570" joined="2016-02-29"/>
    <cosponsor bioguide_id="H001051" joined="2015-05-21"/>
    <cosponsor bioguide_id="H000324" joined="2015-11-03"/>
    <cosponsor bioguide_id="J000032" joined="2016-01-05"/>
    <cosponsor bioguide_id="K000009" joined="2016-04-26"/>
    <cosponsor bioguide_id="K000386" joined="2015-05-21"/>
    <cosponsor bioguide_id="K000382" joined="2016-02-29"/>
    <cosponsor bioguide_id="L000570" joined="2015-11-18"/>
    <cosponsor bioguide_id="M001180" joined="2015-12-08"/>
    <cosponsor bioguide_id="M001196" joined="2016-04-14"/>
    <cosponsor bioguide_id="P000597" joined="2015-12-17"/>
    <cosponsor bioguide_id="R000577" joined="2015-10-21"/>
    <cosponsor bioguide_id="S001196" joined="2015-07-28"/>
    <cosponsor bioguide_id="S001193" joined="2015-12-18"/>
    <cosponsor bioguide_id="T000470" joined="2016-09-06"/>
    <cosponsor bioguide_id="T000469" joined="2015-05-21"/>
    <cosponsor bioguide_id="W000800" joined="2015-10-20"/>
  </cosponsors>
  <actions>
    <action datetime="2015-05-21">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-05-21" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2015-05-21">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2015-05-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2015-06-16">
      <text>Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="Crime, Terrorism, and Homeland Security" code="HSJU08" name="House Judiciary" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="114" relation="identical" number="1455"/>
    <bill type="h" session="114" relation="unknown" number="4435"/>
    <bill type="h" session="114" relation="unknown" number="4396"/>
    <bill type="s" session="114" relation="unknown" number="2562"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government studies and investigations"/>
    <term name="Health facilities and institutions"/>
    <term name="Health personnel"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2015-05-21T04:00:00Z" status="Introduced in House">Recovery Enhancement for Addiction Treatment Act or the TREAT Act

 Amends the Controlled Substances Act to increase the number of patients that a qualifying practitioner dispensing narcotic drugs for maintenance or detoxification treatment is initially allowed to treat from 30 to 100 patients per year.

Allows a qualifying physician, after one year, to request approval to treat an unlimited number of patients under specified conditions, including that he or she: (1) agrees to fully participate in the Prescription Drug Monitoring Program of the state in which the practitioner is licensed, (2) practices in a qualified practice setting, and (3) has completed at least 24 hours of training regarding treatment and management of opiate-dependent patients for substance use disorders provided by specified organizations.

Revises the definition of a "qualifying practitioner" to include: (1) a physician who holds a board certification from the American Board of Addiction Medicine; and (2) a nurse practitioner or physicians assistant who is licensed under state law to prescribe schedule III, IV, or V medications for pain, who has specified training or experience that demonstrates specialization in the ability to treat opiate-dependent patients, who practices under the supervision of, or prescribes opioid addiction therapy in collaboration with, a licensed physician who holds an active waiver to prescribe schedule III, IV, or V narcotic medications for opioid addiction therapy, and who practices in a qualified practice setting.

Directs the Comptroller General to initiate an evaluation of the effectiveness of this Act, including an evaluation of: (1) changes in the availability and use of medication-assisted treatment for opioid addiction, (2) the quality of medication-assisted treatment programs, (3) diversion of opioid addiction treatment medication, and (4) changes in state or local policies and legislation relating to opioid addiction treatment.</summary>
  <committee-reports/>
</bill>
